Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study
This chemotherapy regimen demonstrated satisfactory therapeutic efficacy and manageable toxicity in heavily pretreated PROC, suggesting its potential as a viable treatment alternative.
Authors
- Sijian Li (ORCID: https://orcid.org/0000-0003-1578-0516)
- Linyu Wu (ORCID: https://orcid.org/0000-0002-2021-8336)
- Bingna Xian
- Jundong Li
- Fan Yang
- Lanyue Cui
- Cheng Fang
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1007/s00432-026-06461-5
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00